Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.860
+0.010 (0.54%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Alector Employees
Alector had 103 employees as of December 31, 2025. The number of employees decreased by 135 or -56.72% compared to the previous year.
Employees
103
Change (1Y)
-135
Growth (1Y)
-56.72%
Revenue / Employee
$178,806
Profits / Employee
-$1,217,359
Market Cap
206.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Karyopharm Therapeutics | 228 |
| Codexis | 146 |
| Nkarta | 108 |
| Immunic | 95 |
| Keros Therapeutics | 87 |
| Camp4 Therapeutics | 48 |
| Q32 Bio | 22 |
ALEC News
- 7 weeks ago - Alector reports Q1 EPS (21c), consensus (28c) - TheFly
- 7 weeks ago - Alector Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Alector Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Alector Earnings release: Q1 2026 - Filings
- 7 weeks ago - Alector price target raised to $2 from 90c at Morgan Stanley - TheFly
- 2 months ago - Alector to discontinue PROGRESS-AD trial of nivisnebart - TheFly
- 2 months ago - Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer's Disease Following Interim Futility Analysis - GlobeNewsWire
- 2 months ago - Alector Proxy statement: Proxy filing - Filings